Stock of the Day

July 9, 2020

Cencora (COR)

$287.32
-$1.09 (-0.4%)
Market Cap: $55.51B

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Cencora Bull Case

Here are some ways that investors could benefit from investing in Cencora, Inc.:

  • The current stock price is approximately $289.33, which reflects a strong market position and investor interest.
  • Insider ownership is significant, with 10.80% of the stock held by corporate insiders, indicating confidence in the company's future performance.
  • Recent transactions show that key executives, including the CEO, have made substantial stock sales, which can be interpreted as a strategic move to capitalize on current valuations.
  • Institutional investors hold a remarkable 97.52% of the company's stock, suggesting strong institutional confidence and support for Cencora, Inc.'s business model.
  • Recent increases in stakes by large investors, such as Cornerstone Planning Group LLC, indicate growing interest and potential for future growth.

Cencora Bear Case

Investors should be bearish about investing in Cencora, Inc. for these reasons:

  • Recent insider sales, including a 21.96% decrease in the CEO's position, may raise concerns about the company's short-term outlook.
  • Insiders sold a total of 45,223 shares worth over $12 million in the last quarter, which could signal potential issues or a lack of confidence in the near-term performance.
  • The stock has experienced fluctuations, and the recent average sale price of $289.33 may not reflect long-term stability.
  • With a significant portion of stock held by insiders, any negative news could lead to a rapid decline in stock value, impacting investor confidence.
  • Recent decreases in positions by key executives, such as the chief accounting officer, may indicate a lack of confidence in the company's future growth prospects.
← Previous Stock of the DayNext Stock of the Day →

Recent News